Published in Proc Natl Acad Sci U S A on March 01, 1975
Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 11.24
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest (1989) 10.59
The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med (1976) 7.57
Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J Cell Biol (1977) 7.13
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1977) 5.87
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol (1982) 4.08
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev (2009) 3.65
Collagen-and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med (1976) 3.17
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
Transport of sodium, potassium, and calcium across rabbit polymorphonuclear leukocyte membranes. Effect of chemotactic factor. J Cell Biol (1977) 3.00
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med (2004) 2.96
Motility and adhesiveness in human neutrophils. Effects of chemotactic factors. J Clin Invest (1979) 2.91
Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A (1988) 2.83
Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med (1979) 2.80
Chemotactic peptide receptor modulation in polymorphonuclear leukocytes. J Cell Biol (1980) 2.72
Sensory adaptation of leukocytes to chemotactic peptides. J Cell Biol (1979) 2.61
Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci U S A (1975) 2.56
Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev (2005) 2.50
Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides. J Exp Med (1978) 2.45
The selective eosinophil chemotactic activity of histamine. J Exp Med (1975) 2.45
Role of a peptidase in phagocyte chemotaxis. Proc Natl Acad Sci U S A (1976) 2.38
Modulating influence of chemotactic factor-induced cell adhesiveness on granulocyte function. J Clin Invest (1979) 2.30
Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol (1992) 2.24
Chemotaxis by polymorphonuclear leukocytes. J Cell Biol (1978) 2.20
Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med (1999) 2.20
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A (1990) 2.18
Neutrophils in innate host defense against Staphylococcus aureus infections. Semin Immunopathol (2011) 2.17
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest (1984) 2.10
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10
Pertussis toxin inhibits fMet-Leu-Phe- but not phorbol ester-stimulated changes in rabbit neutrophils: role of G proteins in excitation response coupling. Proc Natl Acad Sci U S A (1985) 2.05
Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med (1982) 2.04
Leucoattractants enhance complement receptors on human phagocytic cells. Clin Exp Immunol (1979) 2.04
Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood (2014) 2.01
Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe (2012) 1.94
Requirement of S-adenosyl-L-methionine-mediated methylation for human monocyte chemotaxis. Proc Natl Acad Sci U S A (1978) 1.89
Some interrelations of neutrophil chemotaxis, lysosomal enzyme secretion, and phagocytosis as revealed by synthetic peptides. Am J Pathol (1976) 1.86
Acute inflammatory pulmonary reactions induced by chemotactic factors. Am J Pathol (1979) 1.79
Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest (1985) 1.79
Intestinal macrophages and response to microbial encroachment. Mucosal Immunol (2010) 1.76
CB2 receptors in the brain: role in central immune function. Br J Pharmacol (2007) 1.66
Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest (1997) 1.66
Interaction of chemotactic factors with human macrophages. Induction of transmembrane potential changes. J Cell Biol (1977) 1.64
Transepithelial migration of human neutrophils: an in vitro model system. Proc Natl Acad Sci U S A (1980) 1.63
Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (1980) 1.60
B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. Proc Natl Acad Sci U S A (1990) 1.60
Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity. J Bacteriol (2003) 1.59
The Vi capsular polysaccharide enables Salmonella enterica serovar typhi to evade microbe-guided neutrophil chemotaxis. PLoS Pathog (2014) 1.57
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol (2008) 1.51
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med (2009) 1.44
Two pathways through Cdc42 couple the N-formyl receptor to actin nucleation in permeabilized human neutrophils. J Cell Biol (2000) 1.44
Chemotaxis of Rhizobium spp. to Plant Root Exudates. Plant Physiol (1976) 1.43
Recognition and response in mononuclear and granular phagocytes. Clin Exp Immunol (1976) 1.41
Danger signals activating the immune response after trauma. Mediators Inflamm (2012) 1.40
Chemotropism indices for polymorphonuclear leukocytes. Biophys J (1976) 1.40
Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes. Clin Exp Immunol (1986) 1.40
Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1979) 1.39
Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc Natl Acad Sci U S A (1983) 1.37
The neutrophil, a professional killer of bacteria, may be controlled by T cells. Clin Exp Immunol (1990) 1.36
Chemical identity of the acrasin of the cellular slime mold Polysphondylium violaceum. Proc Natl Acad Sci U S A (1982) 1.35
Chemotactic deactivation of human neutrophils: evidence for nonspecific and specific components. Infect Immun (1978) 1.33
Chemotactic response of monocytes to thrombin. J Cell Biol (1983) 1.33
Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers. Proc Natl Acad Sci U S A (1982) 1.31
Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by betagamma dimers released by activation of Galphai-coupled receptors. Proc Natl Acad Sci U S A (1997) 1.30
Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils. J Immunol (2008) 1.30
Cdc42 and Rac family GTPases regulate mode and speed but not direction of primary fibroblast migration during platelet-derived growth factor-dependent chemotaxis. Mol Cell Biol (2009) 1.29
A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus. J Clin Invest (1978) 1.28
Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem J (1994) 1.27
Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism. Infect Immun (1979) 1.27
Mechanisms of macrophage activation. Clin Exp Immunol (1980) 1.25
Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24
Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest (1980) 1.24
A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor. Proc Natl Acad Sci U S A (1980) 1.23
Characterization of a class of nonformylated Enterococcus faecalis-derived neutrophil chemotactic peptides: the sex pheromones. Proc Natl Acad Sci U S A (1990) 1.22
Platelet-derived growth factor stimulates mouse 3T3 cell mitogenesis and leukocyte chemotaxis through different structural determinants. J Clin Invest (1983) 1.19
Substances which aggregate neutrophils. Mechanism of action. Am J Pathol (1978) 1.19
Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines. J Exp Med (1980) 1.18
Laminin promotes rabbit neutrophil motility and attachment. J Clin Invest (1986) 1.17
Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation (2007) 1.17
Phospholipid metabolism, calcium flux, and the receptor-mediated induction of chemotaxis in rabbit neutrophils. J Cell Biol (1982) 1.17
Monocyte chemotactic peptide receptor. Functional characteristics and ligand-induced regulation. J Clin Invest (1981) 1.16
H2-M3 restricted presentation of a Listeria-derived leader peptide. J Exp Med (1998) 1.16
Recombinant human monocyte IL-8 primes NADPH-oxidase and phospholipase A2 activation in human neutrophils. Immunology (1992) 1.15
Bacterial chemotaxis toward environmental pollutants: role in bioremediation. Appl Environ Microbiol (2002) 1.14
Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition. Mol Pharmacol (2009) 1.14
Effect of chemoattractants on chemiluminescence. Infect Immun (1978) 1.14
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}. Blood (2008) 1.12
Calcium ionophore, phorbol ester, and chemotactic peptide-induced cytoskeleton reorganization in human neutrophils. J Clin Invest (1987) 1.12
Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect Immun (1993) 1.11
Synthetic peptide chemotactic factors for neutrophils: the range of active peptides, their efficacy and inhibitory activity, and susceptibility of the cellular response to enzymes and bacterial toxins. Immunology (1979) 1.11
Effect of in vitro preincubation of polymorphonuclear leukocytes on formylmethionyl-leucyl-phenylalanine-induced chemiluminescence. Infect Immun (1982) 1.09
Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe (2013) 1.08
Influence of complement on the chemiluminescent response of human leukocytes to immune complex. Infect Immun (1980) 1.07
Acute colitis produced by chemotactic peptides in rats and mice. Am J Pathol (1985) 1.07
Regulation of the affinity state of the N-formylated peptide receptor of neutrophils: role of guanine nucleotide-binding proteins and the cytoskeleton. J Cell Biol (1987) 1.05
Chemoreceptors in bacteria. Science (1969) 12.30
Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol (1968) 5.77
N-formylmethionyl-sRNA as the initiator of protein synthesis. Proc Natl Acad Sci U S A (1966) 5.50
A neutrophil chemotactic factor from human C'5. J Immunol (1969) 4.46
THE NH2-TERMINAL RESIDUES OF THE PROTEINS FROM CELL-FREE EXTRACTS OF E. COLI. J Mol Biol (1963) 4.16
Initiation of E. coli proteins. Proc Natl Acad Sci U S A (1966) 4.07
Acrasin, Acrasinase, and the sensitivity to acrasin in Dictyostelium discoideum. Dev Biol (1969) 3.56
Role of methionine in the initiation of haemoglobin synthesis. Nature (1970) 3.02
Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun (1970) 3.01
On the release of the formyl group from nascent protein. J Mol Biol (1968) 3.00
Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes. Proc Soc Exp Biol Med (1969) 2.76
Translational reinitiation: reinitiation of lac repressor fragments at three internal sites early in the lac i gene of Escherichia coli. Proc Natl Acad Sci U S A (1974) 2.25
Factors from saliva and oral bacteria, chemotactic for polymorphonuclear leukocytes: their possible role in gingival inflammation. J Periodontol (1970) 1.66
Transient incorporation of methionine at the N-terminus of protamine newly synthesized in trout testis cells. Nature (1970) 1.47
In vitro studies of a chemotactic lymphokine in the guinea pig. Int Arch Allergy Appl Immunol (1974) 1.46
Initiation of rabbit hemoglobin synthesis: methionine and formylmethionine at the N-terminal. Proc Natl Acad Sci U S A (1970) 1.44
Surface and cell membrane activities of leukocyte chemotactic factors. Nature (1974) 1.32
Endogenous systhesis of formyl-methionine peptides in isolated mitochondria and chloroplasts. Biochem Biophys Res Commun (1971) 1.26
The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med (1976) 7.57
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol (1999) 5.58
A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci U S A (1980) 4.45
Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol (1982) 4.08
Macrophages as a source of HIV during opportunistic infections. Science (1997) 3.92
Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem Biophys Res Commun (1977) 3.81
Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J Exp Med (1998) 3.56
The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol (1975) 3.50
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol (1984) 3.36
TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity (2001) 3.20
Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol (1978) 3.16
Collagenase production by endotoxin-activated macrophages. Proc Natl Acad Sci U S A (1974) 3.05
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med (1993) 2.98
Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest (1995) 2.95
Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem (1992) 2.93
Collagenase production by lymphokine-activated macrophages. Science (1975) 2.64
Chemoattractants stimulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes. Proc Natl Acad Sci U S A (1979) 2.62
Role of secretory events in modulating human neutrophil chemotaxis. J Clin Invest (1978) 2.59
Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today (1989) 2.56
Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med (2000) 2.48
Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood (1997) 2.41
Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39
Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol (1991) 2.39
Role of a peptidase in phagocyte chemotaxis. Proc Natl Acad Sci U S A (1976) 2.38
Tumor cell autocrine motility factor. Proc Natl Acad Sci U S A (1986) 2.28
Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol (1991) 2.23
Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med (1990) 2.19
Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest (1991) 2.18
Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J Clin Invest (1991) 2.11
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest (1984) 2.10
Transforming growth factor beta: a matter of life and death. J Leukoc Biol (1994) 1.97
Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol (1990) 1.89
The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Comparative studies in arthritis resistant and susceptible inbred rat strains. Arthritis Rheum (1983) 1.83
Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med (2001) 1.82
Role of attachment factors and attractants in fibroblast chemotaxis. J Lab Clin Med (1980) 1.80
Raipid stimulation of protein carboxymethylation in leukocytes by a chemotatic peptide. Nature (1978) 1.77
Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. J Infect Dis (1990) 1.77
Intestinal macrophages and response to microbial encroachment. Mucosal Immunol (2010) 1.76
Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats. J Clin Invest (1985) 1.73
Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res (2001) 1.73
Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol (1999) 1.70
Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest (1997) 1.67
NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment. Ann Intern Med (1984) 1.61
Macrophage production of fibronectin, a chemoattractant for fibroblasts. J Immunol (1981) 1.58
Induction of guinea pig B-cell lymphokine synthesis by mitogenic and nonmitogenic signals to Fc, Ig, and C3 receptors. J Exp Med (1974) 1.53
Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol (1996) 1.51
Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med (1999) 1.49
Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc Natl Acad Sci U S A (1981) 1.47
In vitro studies of a chemotactic lymphokine in the guinea pig. Int Arch Allergy Appl Immunol (1974) 1.46
The cell binding fragment of fibronectin is chemotactic for fibroblasts. Cell Biol Int Rep (1981) 1.45
Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J Immunol (1987) 1.40
Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry (1980) 1.40
Modulation of fibroblast growth by a lymphokine of human T cell continuous T cell line origin. J Immunol (1983) 1.39
Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J Immunol (1991) 1.33
Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun (1991) 1.32
The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol Chem (1989) 1.31
Adult tissues contain chemoattractants for vascular endothelial cells. Nature (1980) 1.30
The role of macrophages in the production of lymphokines by T and B lymphocytes. J Immunol (1975) 1.29
T lymphocyte-dependent evolution of bacterial cell wall-induced hepatic granulomas. J Immunol (1986) 1.29
Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J Periodontol (1993) 1.26
Hepatic fibrosis in schistosomiasis: egg granulomas secrete fibroblast stimulating factor in vitro. Science (1978) 1.25
Inhibition by cyclosporin A of streptococcal cell wall-induced arthritis and hepatic granulomas in rats. Arthritis Rheum (1986) 1.25
The role of the oral environment in HIV-1 transmission. J Am Dent Assoc (1998) 1.24
IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol (1992) 1.24
Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. J Clin Invest (1992) 1.24
Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc Natl Acad Sci U S A (1994) 1.23
Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J Immunol (1993) 1.23
Enzymatic reduction of oxidized chemotactic peptide N-formyl-L-methionyl-sulfoxide-L-leucyl-L-phenylalanine. Biochem Biophys Res Commun (1982) 1.23
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). II. Functional properties of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions. Cell Immunol (1984) 1.22
Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J Immunol (1990) 1.22
Glycolysis as primary energy source in tumor cell chemotaxis. J Natl Cancer Inst (1990) 1.21
Biochemistry of phagocyte chemotaxis. Curr Top Cell Regul (1979) 1.21
Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine. J Immunol (1980) 1.21
Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction. J Exp Med (1985) 1.20
Biochemical mechanisms of tumor invasion and metastases. Prog Clin Biol Res (1988) 1.20
Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis (1990) 1.18
Substance P receptor-mediated chemotaxis of human monocytes. Peptides (1985) 1.18
Complement-induced histamine release from human basophils. I. Generation of activity in human serum. J Immunol (1975) 1.17
Laminin promotes rabbit neutrophil motility and attachment. J Clin Invest (1986) 1.17
Phospholipid metabolism, calcium flux, and the receptor-mediated induction of chemotaxis in rabbit neutrophils. J Cell Biol (1982) 1.17
Development of chemotactic responsiveness in myeloid precursor cells: studies with a human leukemia cell line. Proc Natl Acad Sci U S A (1980) 1.17
Co-expression of chemotactic ligand receptors on human peripheral blood monocytes. J Immunol (1987) 1.16
Investigation of the nature of the intermediates involved in desmosine biosynthesis. Biochem Biophys Res Commun (1967) 1.16
Fibroblast stimulation in schistosomiasis. I. Stimulation in vitro of fibroblasts by soluble products of egg granulomas. J Infect Dis (1981) 1.16
Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures. J Virol (1991) 1.14
Polymorphonuclear leukocyte migration through human amnion membrane. J Cell Biol (1981) 1.13
Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest (1984) 1.11
Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science (1985) 1.10
Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis. J Immunol (1998) 1.10
Leukocyte chemotaxis. Annu Rev Physiol (1982) 1.09
Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration. Nature (1987) 1.08